---
$id: https://graph.org.ai/products/commodity/51111851
$type: Product
source: UNSPSC
code: "51111851"
title: "Histrelin"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Histrelin

**UNSPSC Code**: 51111851
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a gonadotropin-releasing hormone analog, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H50H3S3W74. European Medicines Agency schedules Histrelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08046MIG. Histrelin generally arises in the molecular formula C66H86N18O12. The term HISTRELIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, no. 5, 1985, list 25.) HISTRELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule histrelin under HS 29371900 and SITC 54154. As of Q4 2014, HISTRELIN remains the US FDA Preferred Term for this commodity. Histrelin bears US NLM identifiers UMLS ID C0121902 and NCI Concept Code C74270. SMILES: O=C(N1C(CCC1)C(=O)NCC)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C1NC(=O)CC1)CC1NC[NH]C1)CC1C2C([NH]C1)CCCC2)CO)CC1CCC(O)CC1)CC1NCN(C1)CC1CCCCC1)CC(C)C)CCCNC(=N)N.

